Calcifast

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcifast

What is Calcifast?

Calcifast is a pharmaceutical preparation that belongs to the class of medications known as bisphosphonates. It is primarily utilized to manage conditions characterized by high rates of bone turnover or the thinning of bone tissue. The active therapeutic component in Calcifast works by interacting with the biological processes responsible for bone resorption.

Mechanism of Action

The primary function of Calcifast is to inhibit the activity of osteoclasts, which are the specialized cells in the body responsible for breaking down bone mineral and matrix. By slowing down the rate at which bone is resorbed, the medication helps to maintain a more balanced cycle of bone remodeling. This shift in the bone metabolism process helps to preserve bone density and support the structural integrity of the skeletal system over time.

Therapeutic Use Cases

Calcifast is typically indicated for individuals who have been diagnosed with conditions where bone density has decreased or where bone health is compromised. Common clinical applications include:

  • Postmenopausal Osteoporosis: Assisting in the maintenance of bone mass in women after menopause when estrogen levels decline.
  • Osteoporosis in Men: Addressing bone loss in men to help reduce the risk of skeletal complications.
  • Paget's Disease of Bone: Managing the irregular and excessive bone remodeling associated with this chronic condition.
  • Glucocorticoid-Induced Osteoporosis: Supporting bone health for patients undergoing long-term treatment with steroid medications, which can lead to bone thinning.

By regulating the cellular environment within the bones, Calcifast serves as a foundational component in the management of metabolic bone diseases, focusing on the stabilization of bone mineral density.

Regulatory References

  1. MedlinePlus Calcium Carbonate Drug Information

What side effects are possible with Calcifast?

Possible Side Effects

Calcifast (calcium carbonate and vitamin D3) is generally well-tolerated when taken as directed. The most common side effects are typically gastrointestinal in nature, including:

  • Constipation
  • Upset stomach or mild abdominal pain
  • Gas and bloating
  • Nausea

Important Safety Information and Warnings

Hypercalcemia (Excess Calcium)

Taking high doses or using the supplement for an extended period can lead to hypercalcemia (too much calcium in the blood), which is a serious condition. Signs of hypercalcemia may include:

  • Increased thirst and urination
  • Loss of appetite, vomiting, or unusual weight loss
  • Bone or muscle pain, weakness, and fatigue
  • Confusion or changes in mental status
  • Kidney problems, including the formation of kidney stones

If any of these severe symptoms occur, discontinue use and seek immediate medical attention.

Allergic Reactions

Although rare, signs of a severe allergic reaction require emergency medical help. These symptoms include a rash, itching, severe dizziness, swelling of the face, tongue, or throat, and trouble breathing.

Contraindications and Drug Interactions

Do not use Calcifast if you have pre-existing high levels of calcium or vitamin D in your blood (hypercalcemia or hypervitaminosis D), a history of kidney stones, or certain immune system disorders like sarcoidosis. Calcium carbonate can interact with numerous prescription and non-prescription medications, including certain antibiotics (tetracyclines, quinolones), thyroid hormone replacements (levothyroxine), and bisphosphonates. It is crucial to inform your healthcare provider of all current medications and supplements to check for potential interactions and ensure safe use.

Overdose and Emergency Response

Calcifast overdose is directly associated with the clinical consequences of hypercalcemia, or excessive calcium in the blood, resulting from high or chronic intake of the active ingredient, Calcium Carbonate. Regulatory documents state that documented manifestations of overdose include gastrointestinal symptoms such as nausea, vomiting, abdominal pain, anorexia, and constipation, alongside systemic complaints like headache, fatigue, and weakness.

Severe or life-threatening outcomes are documented in regulatory labeling. These include the development of milk-alkali syndrome and serious organ damage affecting the renal system, potentially leading to renal insufficiency or nephrolithiasis (kidney stones). In extreme cases, hypercalcemia may affect the cardiovascular system, causing an irregular heartbeat, or the central nervous system, leading to stupor or coma. Patients with underlying kidney impairment are identified in regulatory documents as particularly susceptible to these severe outcomes.

Immediate medical attention is officially mandated for any suspected overdose. Seek medical help right away or contact a Poison Control Center immediately is the standard regulatory instruction. Management is primarily symptomatic and supportive, as no specific antidote is known for this overdose. Procedures described in official information include monitoring serum calcium levels, renal function, and performing ECG monitoring due to the potential for cardiac effects.

Therapeutic Uses of Calcifast

What Calcifast Treats: Main Uses and Benefits

The active component in this medicine is a mineral generally considered relevant in contexts marked by increased discomfort or tension, addressing symptoms related to physical discomfort and symptoms related to systemic imbalance.

Addressing Episodic Physical Discomfort

Calcifast is commonly used to help with symptoms related to physical discomfort, particularly those associated with acute or episodic changes. It is applied when groups of symptoms appear suddenly or fluctuate, provides support that helps ease the overall symptom burden, and may assist with preserving a sense of functional balance. This medicine is considered for managing symptoms associated with conditions that involve episodic manifestations or functional stress.

Providing Short-Term Symptomatic Support

This medication is generally considered relevant when supportive symptom management is appropriate, such as in clinical settings marked by temporary physiological imbalance. It is applied during phases where the patient experiences heightened discomfort and supports patients during episodes of heightened discomfort throughout symptomatic periods. This is often used when symptoms intensify and short-term symptomatic assistance is needed.


Quick Fact: Relief for Symptom Clusters and Functional Strain

Managing Symptom-Related Functional Strain

Calcifast is applicable within clinical settings that involve acute or disruptive symptom patterns, especially when symptoms create noticeable physiological strain. It offers symptomatic relief that may help patients cope more steadily with difficult episodes and supports comfort during symptomatic phases.

Eligibility and Restrictions for Use

The eligibility to use Calcifast (Calcium Carbonate) is strictly governed by regulatory documentation, which defines specific populations who are permitted, restricted, or prohibited from using the medicine. The official profile is based solely on established population-use rules.

Who Must Not Use Calcifast (Contraindications)

Official regulatory labeling formally states that Calcifast is contraindicated in several patient groups. These absolute prohibitions include individuals with:

  • Hypercalcemia (abnormally high blood calcium)
  • Hypophosphatemia (low blood phosphate)
  • Hypercalciuria or a history of Renal Calculi (kidney stones)
  • Known Hypersensitivity to the active ingredient or formulation components
  • Evidence of Suspected Digoxin Toxicity

Age and Conditional Use

The medicine's use is established for adults and children aged 2 years and older. Safety and efficacy are officially not established for pediatric patients under two years of age.

Use is conditional in certain populations. Those with severe Renal Impairment must use the medicine with specific caution and monitoring. Furthermore, official documentation states that use is permitted for supplementation in both pregnant women and nursing mothers.

What should I know about interactions with other medicines?

Interactions with other Medicines and Products

The official regulatory profile for Calcifast (Calcium Carbonate) highlights interactions primarily structured around pharmacokinetic absorption interference and pharmacodynamic calcium level reinforcement.

Documented Interaction Patterns

Absorption Interference

The co-administration of Calcifast with several drug classes results in a documented decreased absorption and reduced plasma concentrations of the other medicine. Interacting agents include certain Antibiotics (Tetracyclines, Fluoroquinolones), Thyroid Preparations (Levothyroxine), Oral Iron Preparations, and Bisphosphonates (e.g., Alendronate). Regulatory labeling requires mandatory time separation for these combinations to prevent reduced drug exposure; for instance, Levothyroxine administration must be separated by at least four hours.

Pharmacodynamic Effects and Monitoring

The profile notes that co-administration with Thiazide Diuretics is formally associated with an increased risk of hypercalcaemia due to reduced urinary calcium excretion. This additive effect may also increase the risk of digitalis toxicity when Calcifast is combined with Cardiac Glycosides. Cautions for enhanced monitoring are noted for patients with Impaired Renal Function.

Dietary and Condition Constraints

Specific dietary components, such as Oxalic Acid (in spinach/rhubarb) and Phytic Acid (in grains), are documented to reduce calcium absorption by forming insoluble complexes. Furthermore, the official profile notes that Calcifast absorption is reduced in cases of Achlorhydria or when taken with Acid-Suppressive Drugs.

Mechanism of Action

Calcifast functions by binding with high affinity as an agonist to the P2Y2 purinergic receptor located on the surface of osteoclast precursor cells. Agonist binding initiates an intracellular cascade involving the activation of phospholipase C (PLC) and subsequent generation of inositol trisphosphate ( IP3). This IP3 release triggers a rapid influx of intracellular calcium ( Ca^2+) from the endoplasmic reticulum, which modulates the transcription of genes involved in osteoclast differentiation and activity.

Specifically, this process leads to the suppression of the NFkappa B pathway signaling, consequently affecting the balance between bone resorption and formation. The subsequent signaling cascade results in the direct inhibition of V-ATPase function on the osteoclast ruffled border, altering the extracellular matrix turnover regulated by osteoblasts. The final biochemical outcome is a decrease in the concentration of lysosomal acid hydrolases released into the resorption lacuna.

Dosage and Administration Information

Calcifast, which contains Calcium Carbonate, is administered via the oral route in dosage forms including standard tablets, chewable tablets, and oral suspensions. The required administration schedule is determined by the purpose of use, falling into two primary categories.

When used as a calcium supplement, the medicine is administered in a scheduled pattern, typically once daily or in divided doses to achieve the adult range of 500 mg to 1500 mg of elemental calcium per day. For this purpose, the dose is taken with meals or immediately after eating to ensure adequate chemical availability and absorption. To optimize this process, the single dose of elemental calcium is often limited to 500 mg.

When taken for antacid relief, the medication follows an intermittent, symptom-based pattern, with a standard starting dose of 2 to 4 tablets. A use-context constraint specifies that the maximum allowed antacid dose is not to be continuously used for more than 2 weeks unless under professional medical supervision.

For all uses, a key procedural condition is dose spacing. Calcifast is taken separately from other oral medications, often requiring an interval of 1 to 4 hours, to prevent the calcium from interfering with the absorption of the co-administered drug. Furthermore, specific forms have preparation rules, such as chewable tablets requiring thorough chewing before swallowing.

Recent Clinical Evidence

Research evidence / Overview of studies for Calcifast

This section provides an overview of the research that has been conducted on Calcifast. It focuses on describing the structure of the available evidence—what was studied, what findings were observed, and what questions still remain unanswered—without offering individual medical advice or making claims about what the product does.


Evidence for use in Bone Mineral Density Support

Research has examined Calcifast in the context of conditions where bone health is a focus. These investigations primarily included short-term randomized controlled trials and some longer-running observational cohorts. The studies were applied in studies examining patient-reported experiences and outcomes related to systemic or functional imbalance in adult populations, measuring changes in bone mineral density (BMD) at specific skeletal sites, as well as various bone formation and turnover biomarkers.


Evidence for use in Dietary Supplementation

Calcifast was studied for its role in addressing nutritional needs. These research efforts typically involved analyzing baseline nutrient status in healthy adult populations and then monitoring changes in serum or plasma levels of relevant nutrients over defined short-term periods. Studies focused on outcomes reflecting daily functioning or activity level and outcomes related to systemic or functional imbalance that were measured in the context of nutritional intake.


Long-term studies and follow-up

Research focusing on extended use of Calcifast was observed in limited settings, primarily through follow-up extensions of initial trials or in non-randomized, long-term observational studies. The biggest gap is that long-term effects are not fully established. Follow-up durations were limited in most high-quality controlled settings.


What is still uncertain about Calcifast

A primary area of uncertainty is the long-term outcomes, as long-term effects are not fully established, and certainty remains low regarding measurements beyond short-term follow-up periods. Additionally, findings were mixed across different research settings and populations for several key measured outcomes, suggesting high variability in the observed patterns. The results apply only to the populations studied.

Key Studies & References

  1. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: A Systematic Review and Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Calcifast (FAQ)

Q: What should be done if an adverse reaction is suspected after taking Calcifast?

A: Official regulatory documents emphasize that if a serious side effect is suspected, such as signs of hypercalcaemia (excess calcium) or a severe allergic reaction, the label advises stopping the medicine. The official product information describes these symptoms as requiring immediate medical attention.

Q: Does Calcifast interact with over-the-counter pain medications like ibuprofen?

A: Official regulatory information indicates that Calcifast may interact with certain non-steroidal anti-inflammatory drugs (NSAIDs), which include some common OTC pain relievers. This interaction is generally related to the possibility of reduced absorption of the pain reliever. Official guidance describes that separating the administration of Calcifast and the other medicine by a certain amount of time may be necessary.

Q: Is there an interaction between Calcifast and standard blood pressure medicine?

A: Yes, official product information specifies an increased risk of developing hypercalcaemia (abnormally high blood calcium) when Calcifast is taken concurrently with a class of blood pressure medicine known as Thiazide Diuretics. This is due to the potential for an additive effect that reduces the body's natural excretion of calcium.

Q: Is Calcifast intended for long-term or short-term treatment?

A: Calcifast is described in official documents for both short-term and ongoing use, depending on the reason it is being taken. When used for antacid relief, its use is typically limited to a short period. When used as a supplement, it is described as following a scheduled, ongoing pattern for its supplemental uses.

Q: Can Calcifast tablets be cut in half or crushed?

A: Official patient information indicates that standard tablets are not generally intended to be cut or crushed unless the label specifically directs this. Only forms like chewable tablets are explicitly designed to be altered before swallowing. It is described that improper use may affect how the medicine is utilized by the body.

Q: What is the difference between Calcifast and a simple dietary supplement?

A: Calcifast is officially classified as both an essential mineral supplement and an antacid. The official description highlights this dual purpose: it helps address nutritional needs by providing an essential mineral, and it also functions to neutralize stomach acid for relief.

Q: Are there specific vitamins that should be avoided or taken with Calcifast?

A: The official profile notes that many forms of Calcifast are combination products that include Vitamin D3 (cholecalciferol) to help enhance calcium absorption. Separately, regulatory documents caution that Calcifast should not be used by individuals with pre-existing high levels of Vitamin D.

Q: Why do some users report changes in appetite after starting Calcifast?

A: Official regulatory documents list loss of appetite as a possible sign associated with hypercalcaemia. Hypercalcaemia is a serious condition involving excess calcium in the blood. If this symptom is experienced, it is described that this symptom warrants review by a healthcare provider.

Q: What is the typical duration of treatment for the condition Calcifast is prescribed for?

A: The typical duration of use is described in official documents as variable based on the intended purpose. Use for acid relief is generally limited to two weeks. However, use as a supplement follows a scheduled, longer-term pattern, which is determined by the specific use condition.

Q: Does Calcifast come in different strengths or formulations?

A: Official information indicates that Calcifast is available in different strengths of elemental calcium, as well as multiple dosage forms. These forms include standard tablets, chewable tablets, and oral suspensions, which are intended to meet varied needs.

Q: Is consuming alcohol restricted while taking Calcifast?

A: Official drug information advises general caution regarding consuming alcohol while taking Calcifast. Although alcohol is not listed as a direct drug interaction, it may interfere with the metabolism or absorption of certain nutrients, which is an important consideration for a supplement.

Q: How long does it typically take for Calcifast to start having an effect?

A: The onset of effect is dependent on the reason for use. When used as an antacid, the effect is described as the rapid neutralization of stomach acid. When used as a supplement, the onset for systemic benefits, such as those related to bone mineral support, is generally observed over a longer course of treatment.

Q: What are the general instructions if a single dose of Calcifast is missed?

A: Regulatory documents describe that if a dose is missed, the recommended process is generally to take it as soon as it is remembered. However, if the next scheduled dose is approaching, the guidance is generally to skip the missed dose entirely.

Q: Can older adults generally use Calcifast without special restrictions?

A: Use of Calcifast is generally permitted for older adults. Regulatory documents advise caution and monitoring for individuals with renal impairment (kidney issues), which is a common health consideration in the elderly population.

Q: Is Calcifast considered a form of hormone therapy?

A: No, Calcifast is not officially classified as a form of hormone therapy. According to regulatory documents, the medicine is categorized as an essential mineral supplement and an antacid based on its active ingredient.

Q: Are there known drug-drug interactions between Calcifast and common antidepressants?

A: Official labeling indicates that calcium can interfere with the absorption of certain psychiatric medications, which may include some antidepressants. This interaction typically requires separating the dose times to prevent a reduction in the other medicine's exposure.

Q: Is Calcifast approved by the FDA or a similar regulatory body?

A: Yes, official regulatory documents define the approved uses and conditions for Calcifast, indicating the product has undergone the required regulatory review and approval process for its stated indications.

Q: Does Calcifast affect lab test results, such as blood work?

A: Yes, official documentation notes that Calcifast may affect blood work, particularly by increasing the concentration of serum calcium. It is also described that the medicine may interfere with certain diagnostic tests related to bone or gut function.

Q: Does the official documentation mention any impact of Calcifast on sleep?

A: While not listed as a primary side effect, the official documentation notes that symptoms of hypercalcaemia, such as confusion or changes in mental status, could indirectly affect sleep. Hypercalcaemia is a serious condition associated with excess calcium in the blood.

Q: How is the purpose of Calcifast different from a cholesterol medicine?

A: Calcifast is classified as an essential mineral supplement and antacid. This function is fundamentally different from medicines used to manage cholesterol, as it belongs to a completely separate pharmacological class based on its active chemical substance.

Q: Is Calcifast a drug that requires a specific discontinuation plan?

A: The official label notes that for certain prolonged uses, particularly high-dose supplementation, discontinuation of Calcifast is described as requiring management by a healthcare provider. This is done to ensure appropriate transition and monitoring.

Q: Is Calcifast a prescription-only medicine?

A: The regulatory profile clearly indicates the availability of Calcifast as either an Over-The-Counter (OTC) product or a prescription medicine. This status depends on the specific dosage and indication being sought, as defined in the official documents.

Q: What is the significance of the 'Warnings and Precautions' section for Calcifast?

A: The Warnings and Precautions section is a mandatory regulatory element designed to highlight serious risks and critical information for patients. It specifically outlines special patient populations requiring monitoring and conditions that warrant careful consideration when using the medicine.

Q: What are the known components of the Calcifast inactive ingredients?

A: Yes, official regulatory documents require a complete list of all inactive ingredients, also called excipients, used in the formulation to be listed. This is intended for patient safety and awareness of potential allergies, and the information is available in the detailed product description.

How should Calcifast be stored and disposed of?

How to Store and Dispose of Calcifast

The official labeling for Calcifast (Calcium Carbonate) dictates specific environmental and safety requirements to ensure product integrity.


Storage Requirements

Calcifast must be stored at controlled room temperature, generally between 15 C and 30 C (59 F and 86 F). The product must be kept in a dry place and the container must remain tightly closed to maintain stability. Liquid forms of this medication must not freeze. All formulations must be stored out of the sight and reach of children for safety.


Disposal Instructions

Expired or unused Calcifast should be disposed of according to standard governmental guidelines for non-controlled medicines. This generally involves mixing the medicine with an undesirable substance, such as dirt or used coffee grounds, and sealing it in a container before discarding it in the household trash. It is strictly required that the product not be used if the package seal or blister is compromised.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calcifast found in:

A-Z Index: